46 studies found for:    phenylbutyrate
Show Display Options
RSS Create an RSS feed from your search for:
phenylbutyrate
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
Condition: Spinocerebellar Ataxia Type 3
Interventions: Drug: Placebo;   Drug: Sodium Phenylbutyrate
2 Active, not recruiting Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)
Condition: Pulmonary Tuberculosis
Interventions: Drug: Active Sodium Phenylbutyrate and active cholecalciferol;   Drug: Placebo Sodium Phenylbutyrate plus active cholecalciferol;   Drug: Active Sodium Phenylbutyrate and placebo cholecalciferol;   Drug: Placebo Sodium Phenylbutyrate plus placebo cholecalciferol
3 Recruiting Phenylbutyrate Therapy for Maple Syrup Urine Disease
Condition: Maple Syrup Urine Disease
Interventions: Drug: Phenylbutyrate;   Drug: Placebo powder
4 Terminated Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer
Conditions: Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Recurrent Colon Cancer;   Recurrent Rectal Cancer;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Drug: fluorouracil;   Drug: sodium phenylbutyrate;   Drug: indomethacin;   Biological: recombinant interferon gamma
5 Completed Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Condition: Huntington's Disease
Intervention: Drug: sodium phenylbutyrate
6 Unknown  Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
Conditions: Argininosuccinic Aciduria;   Amino Acid Metabolism, Inborn Errors;   Urea Cycle Disorders
Interventions: Drug: Sodium Phenylbutyrate (Buphenyl-TM);   Drug: Arginine
7 Completed A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)
Condition: Healthy
Interventions: Drug: HPN-100;   Drug: Ammonul;   Drug: Buphenyl
8 Recruiting Comparative Efficacy of Phenylbutyrate vs. Benzoate in Urea Cycle Disorders
Conditions: Urea Cycle Disorders;   Ornithine Transcarbamylase Deficiency
Interventions: Drug: Sodium Benzoate;   Drug: Sodium Phenylbutyrate
9 Completed Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl
Conditions: Diabetes;   Insulin Resistance
Interventions: Drug: sodium phenylbutyrate;   Drug: Placebo
10 Completed Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: sodium phenylbutyrate
11 Completed Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
Conditions: Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: chemotherapy;   Drug: oral sodium phenylbutyrate
12 Recruiting Immune Reconstitution in HIV Disease (IREHIV)
Condition: HIV Infection
Interventions: Drug: vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate);   Drug: Placebo tablets
13 Completed
Has Results
Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children 6-17 Years of Age With Urea Cycle Disorders, With a Long-Term Safety Extension
Condition: Urea Cycle Disorders
Interventions: Drug: HPN-100;   Drug: NaPBA
14 Recruiting Immune Reconstitution in Tuberculosis Disease
Condition: Pulmonary Tuberculosis (TB)
Interventions: Drug: vitamin D (cholecalciferol) and PBA (sodium phenylbutyrate);   Drug: Placebo tablets
15 Recruiting Phenylbutyrate As a Treatment for Abnormal Accumulation of Brain Protein in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Glycerol Phenylbutyrate
16 Terminated
Has Results
Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)
Condition: Cystic Fibrosis
Interventions: Drug: Sodium 4-Phenylbutyrate;   Drug: Genistein (Unconjugated Isoflavones 100);   Drug: Placebo
17 Completed Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis)
Condition: Cystic Fibrosis
Interventions: Drug: Sodium 4-Phenylbutyrate (4PBA);   Drug: Unconjugated Isoflavones 100 (PTI G-4660, 87% Genistein);   Drug: Placebo
18 Terminated
Has Results
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I
Condition: Spinal Muscular Atrophy Type I
Intervention: Drug: sodium phenylbutyrate
19 Active, not recruiting Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Intervention: Drug: Sodium phenylbutyrate (NaPB)
20 Terminated
Has Results
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
Conditions: Spinal Muscular Atrophy Type II;   Spinal Muscular Atrophy Type III
Intervention: Drug: sodium phenylbutyrate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years